Opella Healthcare, which has now passed the first anniversary of Clayton, Dubilier & Rice taking a controlling stake in what was Sanofi’s consumer health business, is the fourth largest player in this industry with what Opella describes as the third largest OTC and VMS portfolio globally.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax certification is verified (where applicable).
This report comes in PPT.
Overview:
Euromonitor International's report on Opella Healthcare Group SAS delivers a detailed strategic analysis of the company's business, examining its performance in the Consumer Health market and the global economy. Company and market share data provide a detailed look at the financial position of Opella Healthcare Group SAS, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Opella Healthcare Group SAS.
This report examines:
- Company share by region and sector
- Brand portfolio
- New product developments
- Marketing and distribution strategies
A detailed SWPT analysis of Opella Healthcare Group SAS provides strategic intelligence on:
- Strengths and weaknesses
- Category and country opportunities for growth
- Challenges and threats from current competition and future prospects
- Global and regional market positions
Research you can trust:
Euromonitor International's company profile reports are written by our Consumer Health research team, a dedicated group of analysts that knows the industry inside and out. Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.
Key Facts
Company Direction
Global Performance: Company Sales and Market Share
Global Performance: Company Growth by Industry
Global Performance: Company Growth vs Industry Growth
Global Performance: Company Sales by Region
Opella Healthcare Group SAS SWOT Analysis
Opella Healthcare Group SAS in Consumer Health: Key Facts
Our expert’s view of Opella Healthcare Group SAS in 2026
Opella Healthcare Group SAS Sales in Consumer Health
Opella Healthcare Group SAS Sales in Consumer Health by Region
Opella Healthcare Group SAS Sales in Consumer Health by Category
Top 20 Markets
Opella Healthcare Group SAS: Top Five Industry Trends and Company Response
Key Trend: Tariff impacts ripple beyond the US
Competitive Position: Relative Performance
Competitive Position: Key Categories
Competitive Position: Key Brands
Competitive Position: Share Changes in 2025-2026
Opella Healthcare ’s Top 10 Growth Markets: Historic vs Forecast
Opella Healthcare Group SAS: Online E-Commerce Portfolio
Opella Healthcare Group SAS: E-Commerce Retail Strategy
New Product Development
M&A and Investment
Company Focus and Future Growth
Growth Opportunities in Consumer Health
Consumer Health
It is the aggregation of OTC, Vitamins and Dietary Supplements (VDS), Sports Nutrition, and Weight Management and Wellbeing
See all of our definitionsWhy buy this report:
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!